Fu'an Lianshida International Trade Co., Ltd. – Trademark Portfolio

Entity Type: 99

Fu'an Lianshida International Trade Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include OSMING. The owner is based in Fu'an, Fujian.

Room 6-D, Building 1, No. 6

Guangchang North Road

Fu'an, Fujian 355000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OSMING
OSMING
Registered 2025

Trademark Classifications

Fu'an Lianshida International Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Fu'an Lianshida International Trade Co., Ltd. have?

Fu'an Lianshida International Trade Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fu'an Lianshida International Trade Co., Ltd. file in?

Fu'an Lianshida International Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Fu'an Lianshida International Trade Co., Ltd.'s most well-known trademarks?

Fu'an Lianshida International Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as OSMING. These are among 1 currently registered trademark in the portfolio.

What is Fu'an Lianshida International Trade Co., Ltd.'s trademark registration success rate?

Fu'an Lianshida International Trade Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.